Physician profile
Lars R Webb
NPI 1205179157
$12,510.95
in general payments reported to CMS, 2019-2025
12 companies · $2,386 in 2025
The $2,386 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,842 · 2020: $2,595 · 2021: $3,533 · 2022: $15.37 · 2023: $151 · 2024: $1,988 · 2025: $2,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Food and Beverage: $867 · Travel and Lodging: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Food and Beverage | $867.00 |
| Travel and Lodging | $158.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,038.34 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $186.75 | 2019-2020 | |
| Allergan, INC. | $107.91 | 2019 | |
| Medtronic, INC. | $36.89 | 2021 | |
| Olympus America INC. | $26.64 | 2019 | |
| Tela Bio, INC. | $25.45 | 2019 | |
| Shire North American Group INC | $17.79 | 2019 | |
| Endo Pharmaceuticals INC. | $17.22 | 2019 | |
| Biom'Up France Sas | $14.28 | 2021 | |
| Aroa Biosurgery Incorporated | $13.71 | 2019 | |
| Novo Nordisk INC | $13.43 | 2019 | |
| Abbvie INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lars Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.